Currently, there are 1.88B common shares owned by the public and among those 1.87B shares have been available to trade.
The company’s stock has a 5-day price change of -7.17% and 14.49% over the past three months. C shares are trading 11.58% year to date (YTD), with the 12-month market performance up to 41.95% higher. It has a 12-month low price of $53.51 and touched a high of $84.74 over the same period. C has an average intraday trading volume of 14.30 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -3.30%, 2.65%, and 17.80% respectively.
Institutional ownership of Citigroup Inc (NYSE: C) shares accounts for 77.21% of the company’s 1.88B shares outstanding.
It has a market capitalization of $147.43B and a beta (3y monthly) value of 1.42. The stock’s trailing 12-month PE ratio is 13.22, while the earnings-per-share (ttm) stands at $5.94. The company has a PEG of 0.53 and the debt-to-equity ratio at 2.85. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.76% over the week and 2.27% over the month.
Analysts forecast that Citigroup Inc (C) will achieve an EPS of 1.9 for the current quarter, 1.82 for the next quarter and 9.31 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 1.8 while analysts give the company a high EPS estimate of 1.8. Comparatively, EPS for the current quarter was 1.75 a year ago. Earnings per share for the fiscal year are expected to increase by 25.32%, and 27.23% over the next financial year. EPS should grow at an annualized rate of 25.11% over the next five years, compared to -5.82% over the past 5-year period.
Looking at the support for the C, a number of firms have released research notes about the stock. Barclays stated their Overweight rating for the stock in a research note on January 06, 2025, with the firm’s price target at $70-$95. Keefe Bruyette coverage for the Citigroup Inc (C) stock in a research note released on December 03, 2024 offered a Outperform rating with a price target of $82. Evercore ISI was of a view on April 04, 2024 that the stock is In-line, while Wells Fargo gave the stock Overweight rating on March 25, 2024, issuing a price target of $70- $80. Goldman on their part issued Buy rating on March 14, 2024.
